News | August 04, 2023
Dabur India posts Q1 FY24 PAT at Rs. 463.88 Cr
The company has posted net profit of Rs. 463.88 crores for the period ended June 30, 2023
The company has posted net profit of Rs. 463.88 crores for the period ended June 30, 2023
The company has reported total income of Rs. 4836.89 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1787.16 crores during the period ended June 30, 2023
The company has reported total income of Rs. 62.15 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1248.51 crores during the period ended June 30, 2023
The company has reported total income of Rs. 135.87 crores during the period ended June 30, 2023
The company has reported total income of Rs. 164.63 crores during the period ended June 30, 2023
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
The company has reported total income of Rs. 6738.4 crores during the period ended June 30, 2023
Astec LifeSciences has reported total income of Rs. 144.55 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
